Progenra, Inc. Receives Approval of Novel Patent for Isopeptidase High Throughput Screening Platform  
7/26/2010 12:34:45 PM

MALVERN, Pa.--(BUSINESS WIRE)--Progenra, Inc., announced today their receipt of an Official Notice of Allowance, dated June 15, 2010, of U.S. Patent Application No. 11/156,707, “Diagnostic and Screening Methods and Kits Associated with Proteolytic Activity.” IP protection of this technology was also recently granted by the European Union. This technology will enable faster drug discovery by improving the ability to identify more selective drugs that modulate the handling of proteins associated with various disease states.